TWI543761B - Non-aqueous adhesive - Google Patents
Non-aqueous adhesive Download PDFInfo
- Publication number
- TWI543761B TWI543761B TW101116638A TW101116638A TWI543761B TW I543761 B TWI543761 B TW I543761B TW 101116638 A TW101116638 A TW 101116638A TW 101116638 A TW101116638 A TW 101116638A TW I543761 B TWI543761 B TW I543761B
- Authority
- TW
- Taiwan
- Prior art keywords
- mass
- lidocaine
- trade name
- paste
- patch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
本發明係關於一種使用利多卡因之醫生用及家庭用之非水性貼附劑。
利多卡因(Lidocaine)係以局部麻醉、表面麻醉為目的而使用。其使用樣態係作為調配有利多卡因之外用劑或調配有利多卡因之貼附劑而提供使用。作為外用劑,有軟膏、乳霜、凍膠、噴劑等,且用於帶狀疱疹後神經痛之治療之皮膚表面麻醉等。作為貼附劑,有水性基劑貼附劑(敷劑)與非水性貼附劑(貼劑)。
作為水性基劑貼附劑,例如有美國Endo Pharmaceuticals公司之LIDODERM(註冊商標),且主要用於帶狀疱疹後神經痛之治療之皮膚表面麻醉,除此以外亦用於各種肌肉之疼痛緩解。水性基劑貼附劑存在如下問題:由於含有水分,故膏體變厚,對皮膚之適應性較差,並且因幾乎沒有黏著力而難以進行長時間之貼附,且由於水分之揮發而產生黏著力或物性之變化。又,為了使利多卡因滲透至肌肉中,必須使利多卡因溶解,因此必須存在利多卡因之溶解用水分。
繼而,作為非水性貼附劑,例如於專利文獻1中,揭示有一種調配有5~30重量%之利多卡因作為局部麻醉劑之謀求帶狀疱疹後神經痛之減輕的技術。又,於專利文獻2中,揭
示有一種調配有5~100重量%之利多卡因之局部麻醉經皮吸收帶的技術。又,於專利文獻3及專利文獻4中,揭示有一種調配有0.5~5質量%之利多卡因之貼附劑之技術。又,於專利文獻5中,揭示有一種調配有10~40質量%之利多卡因之貼附劑之技術。於該等非水性貼附劑中,由於利多卡因未溶解並以結晶狀態存在,故向皮膚下之滲透性較差。
並且,於專利文獻5所揭示之技術中,利多卡因係呈高濃度之調配。利多卡因被指出會對心臟造成不良影響,存在由於長時間使用高濃度之利多卡因而導致之休克、發紅、刺激感等副作用,含有超過5質量%之利多卡因之外用劑被指定為烈性藥而無法用作家庭用(通常用)醫藥品。
另一方面,專利文獻3及專利文獻4所揭示之技術雖然係利多卡因之調配量較少而能夠用作家庭用者,但無法使該少量之利多卡因確實地溶解,於例如12小時以上之較長時間內穩定地釋出利多卡因並滲透至皮膚下,因此就疼痛減輕之效果而言存在問題。
專利文獻1:日本專利第3159688號公報專利文獻2:日本專利特開平7-215850號公報專利文獻3:日本專利特開平9-315964號公報專利文獻4:日本專利特開2001-392501號公報
專利文獻5:WO/2009/060629之國際公開公報
本發明者係著眼於開發具有緩解針穿刺時之皮膚之疼痛之效果的利多卡因作為用以通過皮膚緩解肌肉痛的非水性貼附劑。
因此,首先於膏體中調配少量之利多卡因而並非調配高濃度之利多卡因,進而,為了於較長時間內使該少量之利多卡因於穩定之狀態下經皮吸收並滲透至肌肉中,而著眼於使利多卡因確實地溶解之情況。藉由滿足該要求,而可用作能夠於較長時間內實現肌肉之疼痛緩解之非水性貼附劑。
因此,本發明係使用由有機酸及多元醇所構成之溶解劑,且於膏體中含有0.5~7質量%之利多卡因及/或其反應物,藉此使利多卡因確實地溶解而製成於較長時間內對肌肉之各種疼痛緩解有效之非水性貼附劑。再者,利多卡因及/或其反應物於膏體中之調配量較佳係設為0.1~1 mg/cm2。
作為非水性貼附劑,必須使膏體質量變輕,於將1片貼附劑之尺寸設為14×10 cm之情形時,將膏體質量設為0.84~2.8 g。該膏體中之利多卡因之調配量為0.5~7質量%,因此可將1片貼附劑中之利多卡因設為196 mg以下。
為了使利多卡因均勻且穩定地存在於膏體中並有效地利
用,將利多卡因之調配量設定為0.5~7質量%。其原因在於:若利多卡因之調配量未滿0.5質量%,則肌肉之各種疼痛緩解作用較弱,無法獲得所需之有效性。又,其原因在於,若利多卡因之調配量超過7質量%,則為確保利多卡因之釋出性而必須含有較多之溶解劑,因此導致貼附劑之黏著力變弱而無法維持作為貼附劑之物性,從而無法使貼附劑充分附著於患部;又,其原因在於欲將利多卡因之調配量控制為少量。
根據本發明,可藉由使少量之利多卡因高效地溶解而使利多卡因於較長時間內穩定且確實地釋出。
特別是已知,本發明係著眼於使利多卡因於較長時間內高效地溶解之溶解劑,且利用有機酸與多元醇之混合物構成該溶解劑,藉此可使利多卡因持續且確實地溶解。
作為有機酸,有乙酸、油酸、異硬脂酸等。
作為多元醇,有1,3-丁二醇、丙二醇、二丙二醇、聚乙二醇、丙三醇等。
關於溶解劑與利多卡因之調配比率,最有效的是相對於利多卡因1質量%,溶解劑為0.5~5質量%,藉由該調配比率,可於溶解狀態下穩定地調配利多卡因,可獲得向皮膚之釋出率提高且使藥劑向肌肉滲透之有效性。此處,相對於利多卡因1質量%而將溶解劑設為0.5~5質量%之原因在於:若未滿0.5質量%,則無法穩定地溶解利多卡因,無法獲得利多
卡因之良好之釋出。又,其原因在於:若超過5質量%,則貼附劑之黏著力變弱,對皮膚之貼附力變得不充分。
於膏體中,可使用用於非水性貼附劑之通常之原料,但藉由於基劑中使用彈性體,可確保作為貼附劑之適當之柔軟性。作為用於基劑之彈性體,例如較佳為異戊二烯橡膠、聚異丁烯、苯乙烯異戊二烯橡膠,作為彈性體之調配量,於膏體100質量%中,較佳為10~50質量%,更佳為20~40質量%。
又,關於增強黏著力之黏著賦予樹脂,可自由地調配,且可使用通常用於貼附劑之松香系樹脂、合成石油樹脂、萜烯樹脂、酚樹脂、脂環族石油樹脂等。亦可調配聚丁烯或液體石蠟作為軟化劑,調配薄荷腦或樟腦等作為皮膚刺激劑。又,可使用矽酸酐或氧化鋅等無機類或硬脂酸鋅或聚乙烯吡咯啶酮等作為調整劑。又,亦可使用抗氧化劑、紫外線吸收劑、防腐劑、金屬封阻劑等以製劑之劣化防止為目的之添加劑。
保持混合有該等原料之膏體之載體通常係使用可用於貼附劑之不織布、織布、針織布及膜之單體、或由該等之組合所構成者。覆蓋膏體面之剝離膜通常係使用適度地進行脫模處理之膜。由於有時於載體或剝離膜上吸附有藥劑,故通常材質較佳為聚酯,但若無問題,則不特別地拘泥於材質。
膏體質量較佳為60~200 g/m2之範圍,更佳為80~180
g/m2。再者,若膏體質量未滿60 g/m2,則為了維持充分之利多卡因之效能,必須提高利多卡因相對於膏體整體之調配比率,但於該情形時,無法確保利多卡因之充分之溶解性,且使利多卡因結晶化而無法有效率地向皮膚轉移。又,黏著力之調整較為困難,且對於皮膚,無法維持柔軟且適度之黏著。又,若質量超過200 g/m2,則膏體過重而容易引起膏體壓陷。
本發明之非水性貼附劑之製造方法可為熱熔法或溶劑法等先前實施之通常之製造方法。
根據本發明之非水性貼附劑,可確保於皮膚上貼附12小時後之膏體中之利多卡因的釋出率為10%以上。又,藉由將利多卡因之調配量設為較低,可於長時間之貼附或損傷皮膚等時顯示異常之皮膚透過,或者可於血中濃度不急劇上升之情況下實現副作用之減輕,成為作為用於各種肌肉疼痛之緩解的貼附劑而具有有效性與安全性之非水性貼附劑。
又,儘管利多卡因之調配量為少量,但溶解性良好,因此亦可用作非水性貼附劑之皮膚表面麻醉。
藉由表1對本發明之實施例進行說明。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton
D1161」JSR、Kraton、Elastomer公司製造):18質量%.聚異丁烯(商品名「Himol 6H」、日礦日石公司製造):5質量%.氫化松香酯(商品名「Pinecrystal KE-311」、荒川化學公司製造):12質量%.萜烯樹脂(商品名「YS Resin 1150N」、Yasuhara Chemical公司製造):10質量%.利多卡因:7質量%.1,3-丁二醇(Daicel化學工業公司製造):1.5質量%.油酸(「純化油酸」、日油公司製造):2質量%.液體石蠟(商品名「Hicall」、Kaneda公司製造):43.8質量%.輕質矽酸酐(商品名「Sylysia350」、Fuji Silysia化學公司製造):0.5質量%.二丁基羥基甲苯(商品名「BHT」、本州化學工業公司製造):0.2質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、氫化松香酯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解利多卡因、1,3-丁二醇、油酸而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體
重量成為140 g/m2之方式塗佈該膏體液,貼合包含聚酯之織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之利多卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為0.5。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):15質量%.聚異丁烯(商品名「Himol 6H」):10質量%.萜烯樹脂(商品名「YS Resin 1150N」):20質量%.液體石蠟(商品名「Hicall」):48.3質量%.異硬脂酸(高級醇工業公司製造):1.5質量%.利多卡因:3質量%.1,3-丁二醇(Daicel化學工業公司製造):1.5質量%.輕質矽酸酐(商品名「Sylysia」):0.5質量%.二丁基羥基甲苯(商品名「BHT」):0.2質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解異硬脂酸、利多卡因、1,3-丁二醇而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製之膜上,以膏體重量成為140 g/m2之方式塗佈該膏體液,貼合包含聚酯之織布
並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之利多卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為1。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):18質量%.聚異丁烯(商品名「Himol 6H」):10質量%.萜烯樹脂(商品名「YS Resin 1150N」):20質量%.液體石蠟(商品名「Hicall」):46.9質量%.異硬脂酸(高級醇工業公司製造):1.8質量%.二丙二醇(日油公司製造):0.5質量%.利多卡因:2質量%.輕質矽酸酐(商品名「Sylysia350」):0.5質量%.二丁基羥基甲苯(商品名「BHT」、本州化學工業公司製造):0.3質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解異硬脂酸、利多卡因、二丙二醇而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製之膜上,以膏體重量成為140 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布
並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之利多卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為1.15。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):20質量%.聚異丁烯(商品名「Himol 6H」):8質量%.氫化松香酯(商品名「Pinecrystal KE-311」):20質量%.液體石蠟(商品名「Hicall」):48.2質量%.異硬脂酸(高級醇工業公司製造):1.5質量%.利多卡因:0.5質量%.1,3-丁二醇(Daicel化學工業公司製造):1質量%.輕質矽酸酐(商品名「Sylysia350」):0.5質量%.二丁基羥基甲苯(商品名「BHT」):0.3質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、氫化松香酯、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解異硬脂酸、利多卡因、1,3-丁二醇而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體重量成為160 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之
利多卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為5。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):18質量%.聚異丁烯(商品名「Himol 6H」):5質量%.氫化松香酯(商品名「Pinecrystal KE-311」):12質量%.萜烯樹脂(商品名「YS Resin 1150N」):10質量%.液體石蠟(商品名「Hicall」):38.1質量%.異硬脂酸(高級醇工業公司製造):2.1質量%.利多卡因:7質量%.二丙二醇(日油公司製造):7質量%.輕質矽酸酐(商品名「Sylysia350」):0.5質量%.二丁基羥基甲苯(商品名「BHT」):0.3質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、氫化松香酯、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解異硬脂酸、利多卡因、二丙二醇而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體重量成為100 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之利多
卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為1.3。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):20質量%.聚異丁烯(商品名「Himol 6H」):8質量%.萜烯樹脂(商品名「YS Resin 1150N」):20質量%.液體石蠟(商品名「Hicall」):49.165質量%.異硬脂酸(高級醇工業公司製造):1.4質量%.利多卡因:0.7質量%.二丙二醇(日油公司製造):0.035質量%.輕質矽酸酐(商品名「Sylysia350」):0.5質量%.二丁基羥基甲苯(商品名「BHT」、本州化學工業公司製造):0.2質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解異硬脂酸、利多卡因、二丙二醇而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體重量成為150 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。該製劑之利多
卡因與溶解劑之調配比率以質量比計係相對於利多卡因1,溶解劑成為2.05。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):20質量%.聚異丁烯(商品名「Himol 6H」):5質量%.氫化松香酯(商品名「Pinecrystal KE-311」):15質量%.萜烯樹脂(商品名「YS Resin 1150N」):5質量%.液體石蠟(商品名「Hicall」):48.2質量%.聚山梨醇酯80(日油公司製造):4質量%.利多卡因:2質量%.輕質矽酸酐(商品名「Sylysia350」):0.5質量%.二丁基羥基甲苯(商品名「BHT」):0.3質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、氫化松香酯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入另外於80℃混合溶解聚山梨醇酯80、利多卡因而成之溶液,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體重量成為140 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。
.苯乙烯-異戊二烯-苯乙烯嵌段共聚物(商品名「Kraton D1161」):15質量%.聚異丁烯(商品名「Himol 6H」):10質量%.萜烯樹脂(商品名「YS Resin 1150N」):20質量%.液體石蠟(商品名「Hicall」):51.3質量%.利多卡因:3質量%.輕質矽酸酐(商品名「Sylysia350」、Fuji Silysia化學公司製造):0.5質量%.二丁基羥基甲苯(商品名「BHT」):0.2質量%
利用上述調配之材料之製造方法係將苯乙烯-異戊二烯-苯乙烯嵌段共聚物、聚異丁烯、萜烯樹脂、輕質矽酸酐、二丁基羥基甲苯及液體石蠟放入溶解攪拌器中,於150℃加熱溶解後,投入利多卡因,於140℃加熱混合直至變得均勻,從而製成膏體液。於經矽處理之聚酯製膜上,以膏體重量成為140 g/m2之方式塗佈該膏體液,貼合包含聚酯之不織布並使其冷卻後,剪切成約14 cm×10 cm之長方形。
對於藉由實施例1~6及比較例1、2而獲得之製劑,進行以下之項目之實驗。
基於醫藥品製造方針所記載之試驗方法,進行滾珠黏著(Ball Tack)黏著力試驗。如表2所示,實施例1~實施例6(以下稱為本發明品)顯示良好之黏著力。相對於此,於比較例1中,顯示約實施例1~實施例6之一半之值。比較例2由於未使用溶解劑,故於黏著力方面不存在問題。
如圖1所示,於人皮膚上貼附4小時、8小時及12小時,每經過一段時間分別剝下製劑,測定殘存於製劑中之藥劑,算出將貼附前之藥劑量設為100%之情形時之藥劑殘存率。
貼附12小時後之藥劑殘存率,係相對於比較例96~99%,本發明品均顯示為80%以下,向人皮膚之藥劑釋出量為20%以上。
於人皮膚上貼附12小時後,剝下製劑,於製劑貼附過程中經過4小時、8小時及12小時、與剝下製劑後經過24小時後,採取血液,測定利多卡因之血中濃度。將其結果示於圖2之圖表。
可知由異硬脂酸與二丙二醇構成溶解劑者可獲得總體而言較佳之結果。
圖1係顯示藥劑殘存率之圖表。
圖2係顯示血中濃度之圖表。
Claims (4)
- 一種非水性貼附劑,其特徵在於:於基劑中含有0.5~7質量%之利多卡因(Lidocaine),並含有由異硬脂酸或油酸構成之有機酸、及多元醇所構成之溶解劑。
- 如申請專利範圍第1項之非水性貼附劑,其中,將利多卡因於膏體中之調配量設為0.1~1mg/cm2。
- 如申請專利範圍第1項之非水性貼附劑,其中,將多元醇設為二丙二醇或1,3-丁二醇。
- 如申請專利範圍第1項之非水性貼附劑,其中,將溶解劑與利多卡因之調配比率設為相對於利多卡因1質量%,溶解劑為0.5~5質量%。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2011/060781 WO2012153396A1 (ja) | 2011-05-10 | 2011-05-10 | 非水性貼付剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201249431A TW201249431A (en) | 2012-12-16 |
TWI543761B true TWI543761B (zh) | 2016-08-01 |
Family
ID=47138899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101116638A TWI543761B (zh) | 2011-05-10 | 2012-05-10 | Non-aqueous adhesive |
Country Status (9)
Country | Link |
---|---|
US (2) | US9283174B2 (zh) |
EP (2) | EP2708229B1 (zh) |
JP (1) | JP5856153B2 (zh) |
BR (2) | BR112013028802B1 (zh) |
CA (1) | CA2835595C (zh) |
ES (1) | ES2743524T3 (zh) |
MX (2) | MX368747B (zh) |
TW (1) | TWI543761B (zh) |
WO (1) | WO2012153396A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11786455B2 (en) | 2011-05-10 | 2023-10-17 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
JP5856153B2 (ja) | 2011-05-10 | 2016-02-09 | 伊藤忠ケミカルフロンティア株式会社 | 非水性貼付剤 |
US9925264B2 (en) | 2011-05-10 | 2018-03-27 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
LT2823815T (lt) | 2011-09-27 | 2018-08-27 | Itochu Chemical Frontier Corporation | Nevandeninis pleistras |
JP6222521B2 (ja) * | 2013-11-28 | 2017-11-01 | 荒川化学工業株式会社 | 合わせガラス用中間膜および合わせガラス |
CN104188939B (zh) * | 2014-08-20 | 2017-07-04 | 北京泰德制药股份有限公司 | 一种含有利多卡因或其药用盐的局部外用贴片剂 |
EP3331515A1 (en) * | 2015-08-24 | 2018-06-13 | Itochu Chemical Frontier Corporation | Non-aqueous patch comprising lidocaine |
JP6209749B2 (ja) * | 2015-12-10 | 2017-10-11 | 伊藤忠ケミカルフロンティア株式会社 | 非水性貼付剤 |
JP7058856B2 (ja) * | 2016-08-12 | 2022-04-25 | 株式会社サクラクレパス | 粘着付与剤含有光硬化性人工爪組成物 |
WO2018052039A1 (ja) * | 2016-09-16 | 2018-03-22 | ニチバン株式会社 | 貼付剤 |
JP6290521B1 (ja) * | 2016-09-16 | 2018-03-07 | ニチバン株式会社 | 貼付剤 |
SG11202007131UA (en) | 2018-01-24 | 2020-08-28 | Hisamitsu Pharmaceutical Co | Patch |
JP7179212B1 (ja) | 2022-05-02 | 2022-11-28 | 久光製薬株式会社 | リドカイン含有貼付剤 |
Family Cites Families (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970009886B1 (ko) | 1981-08-30 | 1997-06-19 | 히사미쯔세이야꾸 가부시기가이샤 | 소염진통 첩부제 |
SE451669C (sv) | 1984-02-17 | 1989-04-07 | Moelnlycke Ab | Kompress innehaallande zinkoxid |
IL86170A (en) | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
EP0387751B1 (en) | 1989-03-15 | 1994-06-08 | Nitto Denko Corporation | Medicated plasters |
CA1338779C (en) | 1989-03-17 | 1996-12-10 | Harry Hind | Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics |
US5411738A (en) | 1989-03-17 | 1995-05-02 | Hind Health Care, Inc. | Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine |
US5098417A (en) | 1990-04-12 | 1992-03-24 | Ricoh Kyosan, Inc. | Cellulosic wound dressing with an active agent ionically absorbed thereon |
JP3115625B2 (ja) | 1991-03-30 | 2000-12-11 | 帝國製薬株式会社 | リドカイン含有外用貼付剤 |
US5804213A (en) | 1991-10-09 | 1998-09-08 | Lectec Corporation | Biologically active aqueous gel wound dressing |
DE4224325C1 (de) | 1992-07-23 | 1994-02-10 | Sanol Arznei Schwarz Gmbh | Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung |
US6315772B1 (en) | 1993-09-24 | 2001-11-13 | Transmedica International, Inc. | Laser assisted pharmaceutical delivery and fluid removal |
JPH07215850A (ja) | 1994-02-04 | 1995-08-15 | Sekisui Chem Co Ltd | 局所麻酔用経皮吸収テープ |
US5536263A (en) | 1994-03-30 | 1996-07-16 | Lectec Corporation | Non-occulusive adhesive patch for applying medication to the skin |
IL113034A (en) | 1994-04-05 | 2000-02-17 | Astra Ab | Topical dressing |
US5618274A (en) | 1994-04-08 | 1997-04-08 | Rosenthal; Kenneth J. | Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia |
SE9401620L (sv) | 1994-05-10 | 1996-01-10 | Alpharma Ab | Kombinerad användning av lokalbedövningsmedel och täckande förband |
US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
US6461644B1 (en) | 1996-03-25 | 2002-10-08 | Richard R. Jackson | Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods |
FR2748207B1 (fr) | 1996-05-06 | 1998-06-12 | Cird Galderma | Composition a base d'un compose modulant la reactivite des fibres nerveuses |
JPH09315964A (ja) | 1996-05-27 | 1997-12-09 | Chinhin Boku | 肩こり・五十肩治療用貼付剤 |
EP1024833A1 (en) | 1996-07-11 | 2000-08-09 | Farmarc Nederland B.V. | Pharmaceutical composition containing acid addition salt of basic drug |
US5985317A (en) | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
US6365178B1 (en) | 1996-09-06 | 2002-04-02 | Watson Pharmaceuticals, Inc. | Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions |
JPH10147521A (ja) | 1996-09-18 | 1998-06-02 | Yuutoku Yakuhin Kogyo Kk | 持続性疼痛緩和用貼付剤 |
WO1998014184A1 (fr) | 1996-10-04 | 1998-04-09 | Saitama Daiichi Seiyaku Kabushiki Kaisha | Timbre percutane |
JPH1149670A (ja) | 1997-08-04 | 1999-02-23 | Nichiban Co Ltd | 局所麻酔用経皮吸収型製剤 |
US5891919A (en) | 1997-09-19 | 1999-04-06 | Burlington Bio-Medical & Scientific Corp. | Denatonium capsaicinate and methods of producing the same |
AU750809B2 (en) | 1997-09-26 | 2002-07-25 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
FR2770843B1 (fr) | 1997-11-13 | 2000-01-14 | Lavipharm Lab | Association prolamines-lipides polaires vegetaux, son procede de preparation et ses applications |
US6120792A (en) | 1998-04-29 | 2000-09-19 | Juni; Jack E. | Medicated skin patch and method for its use |
US6264927B1 (en) | 1998-08-27 | 2001-07-24 | Elmer P. Monahan | Topical solution and method for the treatment of nail fungus |
JP3159688B2 (ja) * | 1998-10-05 | 2001-04-23 | 祐徳薬品工業株式会社 | 経皮吸収テープ剤 |
CA2318047A1 (en) * | 1998-10-05 | 2000-04-13 | Yutoku Pharmaceutical Ind. Co., Ltd. | Tape material for transcutaneous absorption |
US7127285B2 (en) | 1999-03-12 | 2006-10-24 | Transport Pharmaceuticals Inc. | Systems and methods for electrokinetic delivery of a substance |
US6689380B1 (en) | 1999-05-17 | 2004-02-10 | Kevin S. Marchitto | Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
US6299902B1 (en) | 1999-05-19 | 2001-10-09 | The University Of Georgia Research Foundation, Inc. | Enhanced transdermal anesthesia of local anesthetic agents |
US6580011B1 (en) | 1999-07-29 | 2003-06-17 | Barbara Jennings-Spring | Circumcision/penile dressing |
US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
US6383511B1 (en) | 1999-10-25 | 2002-05-07 | Epicept Corporation | Local prevention or amelioration of pain from surgically closed wounds |
US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
AU4842100A (en) | 1999-12-10 | 2001-06-18 | Teri Buseman | Anti pruritic patch |
WO2001043729A1 (fr) | 1999-12-15 | 2001-06-21 | Hisamitsu Pharmaceutical Co., Inc. | Preparations d'adhesifs |
US6455066B1 (en) | 2000-03-10 | 2002-09-24 | Epicept Corporation | Intradermal-penetration agents for topical local anesthetic administration |
JP2001302501A (ja) | 2000-04-17 | 2001-10-31 | Oishi Koseido:Kk | 肩こり・膝関節痛・五十肩等の治療用貼付剤 |
IL152473A0 (en) | 2000-04-28 | 2003-05-29 | Sloan Kettering Inst Cancer | Topical anesthetic/opioid formulations and uses thereof |
BR0111580A (pt) | 2000-06-13 | 2003-09-16 | Hisamitsu Pharmaceutical Co | Curativo |
GB0015617D0 (en) | 2000-06-26 | 2000-08-16 | Vectura Ltd | Improved preparations for dermal delivery of active substances |
JP4787397B2 (ja) | 2000-08-28 | 2011-10-05 | 日東電工株式会社 | 粘着剤組成物および粘着テープもしくはシート |
US7288265B1 (en) | 2000-10-16 | 2007-10-30 | Lectec Corporation | Treating viral infection at smallpox vaccination site |
WO2002045701A2 (en) | 2000-12-05 | 2002-06-13 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
US6830758B2 (en) | 2001-04-02 | 2004-12-14 | Lectec Corporation | Psoriasis patch |
US7094228B2 (en) | 2001-07-31 | 2006-08-22 | Zars, Inc. | Methods and formulations for photodynamic therapy |
US20030124174A1 (en) | 2001-10-25 | 2003-07-03 | Endo Pharmaceuticals, Inc | Method for treating non-neuropathic pain |
JP2003137773A (ja) | 2001-10-31 | 2003-05-14 | Hisamitsu Pharmaceut Co Inc | 積層支持体を有する貼付剤 |
TWI312885B (en) | 2001-12-06 | 2009-08-01 | Nec Lcd Technologies Ltd | Semi-transmissive liquid crystal display device |
GB2382778B (en) | 2001-12-07 | 2005-02-16 | Blatchford & Sons Ltd | An orthotic strut component |
US7921999B1 (en) | 2001-12-20 | 2011-04-12 | Watson Laboratories, Inc. | Peelable pouch for transdermal patch and method for packaging |
JP2003191659A (ja) | 2001-12-25 | 2003-07-09 | Fuji Photo Film Co Ltd | 平版印刷版用アルミニウム支持体とその製造方法、および平版印刷原版 |
CA2476622C (en) * | 2002-02-19 | 2010-08-03 | Hisamitsu Pharmaceutical Co., Inc. | A transdermal patch |
US7655038B2 (en) | 2003-02-28 | 2010-02-02 | Biointeractions Ltd. | Polymeric network system for medical devices and methods of use |
JP4792193B2 (ja) | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
US7166641B2 (en) | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
US20040076671A1 (en) | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
DE10260873A1 (de) | 2002-12-23 | 2004-07-15 | Beiersdorf Ag | Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin |
US7993654B2 (en) | 2002-12-23 | 2011-08-09 | Beiersdorf Ag | Self-adhesive polymer matrix containing sea algae extract |
US7179477B2 (en) | 2003-08-15 | 2007-02-20 | Shyam K Gupta | Cosmetic dermabrasion treatment system |
US6998109B1 (en) | 2004-01-07 | 2006-02-14 | Pearson Research & Development Limited | Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity |
AU2005209110B2 (en) | 2004-01-29 | 2010-07-01 | Medrx Co., Ltd. | Anti-inflammatory analgesic for external use |
US8741332B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
WO2006017632A1 (en) | 2004-08-04 | 2006-02-16 | Cassel Douglas R | An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain |
EP1807033B1 (en) | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
EP1959931A4 (en) * | 2005-12-14 | 2012-08-22 | Zars Pharma Inc | COMPOSITIONS AND METHODS FOR THE DERMAL TREATMENT OF PAIN |
JP5037831B2 (ja) | 2006-02-15 | 2012-10-03 | 久光製薬株式会社 | 凝集力向上及び徐放化の外用貼付剤 |
CA2642487A1 (en) | 2006-02-17 | 2007-08-30 | Nathan D. Zasler | Novel application of topical anesthetics for modulation of neurogenic tremor |
US7910135B2 (en) | 2006-10-13 | 2011-03-22 | Uluru Inc. | Hydrogel wound dressing and biomaterials formed in situ and their uses |
EP2078524B1 (en) | 2006-10-27 | 2016-08-31 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch |
US7904146B2 (en) | 2006-11-13 | 2011-03-08 | Travanti Pharma Inc. | Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions |
US8236417B2 (en) | 2006-12-01 | 2012-08-07 | Kuraray Co., Ltd. | Pressure-sensitive adhesive for optical films |
EP2128123A4 (en) | 2007-01-29 | 2011-04-20 | Medrx Co Ltd | NON-STEROIDAL ANTI-INFLAMMATORY SALT AND ORGANIC AMINO COMPOUND AND USE THEREOF |
EP2210599B1 (en) * | 2007-11-11 | 2014-09-10 | Medrx Co., Ltd. | Lidocaine tape preparation |
JP5130026B2 (ja) | 2007-11-16 | 2013-01-30 | 日東電工株式会社 | 貼付剤および貼付製剤 |
US20090297591A1 (en) | 2008-05-30 | 2009-12-03 | Orient Pharma Co., Ltd. | Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
WO2010016219A1 (ja) * | 2008-08-05 | 2010-02-11 | 株式会社メドレックス | 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法 |
US20100092544A1 (en) | 2008-10-14 | 2010-04-15 | Katsuhiro Okada | Adhesive composition for patch and use thereof |
US8815261B2 (en) | 2009-06-19 | 2014-08-26 | Medrx Co., Ltd. | Composition for external application comprising aripiprazole and organic acid as active ingredients |
US9375422B2 (en) | 2009-07-24 | 2016-06-28 | Teikoku Seiyaku Co., Ltd. | Fentanyl-containing adhesive preparation for external use |
TWI482645B (zh) | 2010-01-07 | 2015-05-01 | Teikoku Seiyaku Kk | 含有待克菲那(diclofenac)羥乙基吡咯啶之外用油性敷貼劑 |
US9925264B2 (en) * | 2011-05-10 | 2018-03-27 | Itochu Chemical Frontier Corporation | Non-aqueous patch |
JP5856153B2 (ja) | 2011-05-10 | 2016-02-09 | 伊藤忠ケミカルフロンティア株式会社 | 非水性貼付剤 |
LT2823815T (lt) | 2011-09-27 | 2018-08-27 | Itochu Chemical Frontier Corporation | Nevandeninis pleistras |
EP3331515A1 (en) | 2015-08-24 | 2018-06-13 | Itochu Chemical Frontier Corporation | Non-aqueous patch comprising lidocaine |
WO2019220420A1 (en) | 2018-05-18 | 2019-11-21 | Pedranti William | Non-aqueous patch with superior adhesion characteristics |
-
2011
- 2011-05-10 JP JP2013513852A patent/JP5856153B2/ja active Active
- 2011-05-10 CA CA2835595A patent/CA2835595C/en active Active
- 2011-05-10 BR BR112013028802-7A patent/BR112013028802B1/pt active IP Right Grant
- 2011-05-10 EP EP11865320.3A patent/EP2708229B1/en active Active
- 2011-05-10 MX MX2017009966A patent/MX368747B/es unknown
- 2011-05-10 ES ES11865320T patent/ES2743524T3/es active Active
- 2011-05-10 US US14/116,730 patent/US9283174B2/en active Active
- 2011-05-10 WO PCT/JP2011/060781 patent/WO2012153396A1/ja active Application Filing
- 2011-05-10 EP EP19180829.4A patent/EP3569227A1/en active Pending
- 2011-05-10 MX MX2013013121A patent/MX349572B/es active IP Right Grant
- 2011-05-10 BR BR122021017591-8A patent/BR122021017591B1/pt active IP Right Grant
-
2012
- 2012-05-10 TW TW101116638A patent/TWI543761B/zh active
-
2020
- 2020-07-28 US US16/941,429 patent/US11278623B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
BR112013028802A2 (pt) | 2018-06-12 |
MX2013013121A (es) | 2014-08-26 |
BR112013028802B1 (pt) | 2021-10-26 |
MX368747B (es) | 2019-10-14 |
US11278623B2 (en) | 2022-03-22 |
WO2012153396A1 (ja) | 2012-11-15 |
CA2835595C (en) | 2019-02-12 |
EP3569227A1 (en) | 2019-11-20 |
TW201249431A (en) | 2012-12-16 |
EP2708229A1 (en) | 2014-03-19 |
CA2835595A1 (en) | 2012-11-15 |
MX349572B (es) | 2017-08-03 |
JP5856153B2 (ja) | 2016-02-09 |
US20210077626A1 (en) | 2021-03-18 |
JPWO2012153396A1 (ja) | 2014-07-28 |
US9283174B2 (en) | 2016-03-15 |
US20140171509A1 (en) | 2014-06-19 |
BR122021017591B1 (pt) | 2022-05-10 |
ES2743524T3 (es) | 2020-02-19 |
EP2708229A4 (en) | 2014-11-19 |
EP2708229B1 (en) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI543761B (zh) | Non-aqueous adhesive | |
EP2823815B1 (en) | Non-aqueous patch | |
JP5581080B2 (ja) | 外用貼付剤 | |
US10765749B2 (en) | Non-aqueous patch | |
JP2010280634A (ja) | 消炎鎮痛貼付剤 | |
EP3207923B1 (en) | Adhesive patch | |
CN107921007B (zh) | 贴剂 | |
US11786455B2 (en) | Non-aqueous patch | |
JP6209749B2 (ja) | 非水性貼付剤 | |
WO2016208729A1 (ja) | ナルフラフィン含有経皮吸収貼付剤 | |
JP2005350403A (ja) | 貼付剤 |